与慢性阻塞性肺部疾病患者滥用软雾吸入器相关的危险因素
Jong Geol Jang1, Young Seok Lee1, Kyung Soo Hong1
1Division of Pulmonology and Allergy, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Republic of Korea.
概括
软雾吸入器 (SMI) 的滥用在COPD患者中很常见,其中85.5%的人滥用该设备. 低教育程度,高COPD评估测试 (CAT) 成绩和早期疾病持续时间是SMI滥用的关键风险因素.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 肺部疾病 肺部疾病
- 吸入器设备技术 吸入器设备技术
背景情况:
- 吸入式支气管扩展剂对于治疗慢性阻塞性肺病 (COPD) 是必不可少的.
- 软雾吸入器 (SMIs) 的设计是为了改进传统的吸入器类型.
- 人们注意到SMI经常出现处理错误,但在COPD患者中SMI的滥用研究不足.
研究的目的:
- 为了评估SMI在COPD患者中的滥用SMI的流行率.
- 为了确定在这个人群中导致SMI滥用的特定风险因素.
主要方法:
- 采用了前性,观察性,横截面研究设计.
- 在2018年1月至2020年3月期间使用SMI的159名COPD患者被纳入.
- 一位高级护士从业人员评估了使用检查清单的设备处理情况.
主要成果:
- 报告说,吸入器滥用率很高,影响了136名 (85.5%) 的参与者.
- 与滥用的积极关联包括COPD持续时间和COPD评估测试 (CAT) 成绩.
- 对于坚持和教育水平,观察到与滥用有负面关联.
- 多变量分析确定了低教育程度 (<高中),高CAT得分 (≥10) 和短时间的COPD持续时间 (≤2年) 作为显著的风险因素.
结论:
- 在被诊断为COPD的患者中,SMI的滥用是普遍存在的问题.
- 临床医生必须密切监测SMI的使用,特别是在COPD诊断后的初始阶段.
相关概念视频
01:23Inhaled Medications
252
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
252
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:26COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K